Industry Strength Score
22/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
AVALON GLOBOCARE CORP (AVCO) Stock Price & Overview
NASDAQ:AVCO • US05344R1041
Current stock price
0.5259 USD
-0.1 (-16.52%)
At close:
0.601 USD
+0.08 (+14.28%)
After Hours:
The current stock price of AVCO is 0.5259 USD. Today AVCO is down by -16.52%. In the past month the price increased by 4.7%. In the past year, price decreased by -49.43%.
AVCO Key Statistics
52-Week Range0.38 - 1.07
Current AVCO stock price positioned within its 52-week range.
1-Month Range0.38 - 0.7488
Current AVCO stock price positioned within its 1-month range.
- Market Cap
- 46.823M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.10
- Dividend Yield
- N/A
AVCO Stock Performance
Today
-16.52%
1 Week
+37.63%
1 Month
+4.70%
3 Months
-25.32%
Longer-term
6 Months +16.92%
1 Year -49.43%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
AVCO Stock Chart
AVCO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AVCO. When comparing the yearly performance of all stocks, AVCO is a bad performer in the overall market: 80.4% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
AVCO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVCO. Both the profitability and financial health of AVCO have multiple concerns.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AVCO Earnings
Next Earnings DateNov 22, 2022
Last Earnings DateAug 15, 2022
PeriodQ2 / 2022
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
AVCO Forecast & Estimates
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
AVCO Financial Highlights
Over the last trailing twelve months AVCO reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 27.93% compared to the year before.
Income Statements
Revenue(TTM)1.41M
Net Income(TTM)-8.46M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -600.07% | ||
| ROA | -82.31% | ||
| ROE | N/A | ||
| Debt/Equity | 14 |
Chartmill High Growth Momentum
EPS Q2Q%18.38%
Sales Q2Q%3.78%
EPS 1Y (TTM)27.93%
Revenue 1Y (TTM)5.16%
AVCO Ownership
Ownership
Inst OwnersN/A
Shares89.03M
Float37.78M
Ins Owners66.28%
Short Float %N/A
Short RatioN/A
AVCO Industry Overview
AVCO operates in the Real Estate Operating Companies sub-industry within the Real Estate sector. This group contains 18 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
29/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
11%
Outperformed 11% of sub-industries
3 Month Rank
33%
Outperformed 33% of sub-industries
6 Month Rank
24%
Outperformed 24% of sub-industries
Industry Fundamentals & Breadth
- Members
- 18
- New Highs
- 5.6%
- New Lows
- 5.6%
- Average ROE
- 7.5%
- Average Profit Margin
- 17.1%
- Average Operating Margin
- 46.6%
- Average P/E
- 41.1
- Average Fwd P/E
- 34.9
- Average Debt/Equity
- 1.6
AVCO Competitors/Peers
The largest stocks on the US markets in the "Real Estate Operating Companies" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | 34.91 | 5.296B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.508B | ||
| FRPH | FRP HOLDINGS INC | N/A | 397.106M | ||
| TCI | TRANSCONTINENTAL REALTY INV | N/A | 321.581M | ||
| MLP | MAUI LAND & PINEAPPLE CO | N/A | 302.421M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 285.696M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 222.062M | ||
| OZ | BELPOINTE PREP LLC- CLASS A | N/A | 205M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 143.616M | ||
| LPA | LOGISTIC PROPERTIES OF THE A | N/A | 113.516M | ||
| INTG | INTERGROUP CORP | N/A | 90.795M | ||
| MAYS | MAYS (J.W.) INC | N/A | 81.77M | ||
| CKX | CKX LANDS INC | N/A | 23.514M |
Related stock screener links
View all stocks in the Real Estate Operating Companies Industry | View all stocks in the Real Estate Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVCO
Company Profile
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
Company Info
IPO: 2016-02-22
AVALON GLOBOCARE CORP
4400 ROUTE 9, SUITE 3100
Freehold NEW JERSEY 07728 US
CEO: David Jin
Employees: 5
Phone: 17327804400.0
AVALON GLOBOCARE CORP / AVCO FAQ
What does AVALON GLOBOCARE CORP do?
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
What is the stock price of AVALON GLOBOCARE CORP today?
The current stock price of AVCO is 0.5259 USD. The price decreased by -16.52% in the last trading session.
Does AVCO stock pay dividends?
AVCO does not pay a dividend.
What is the ChartMill rating of AVALON GLOBOCARE CORP stock?
AVCO has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is AVCO stock listed?
AVCO stock is listed on the Nasdaq exchange.
What is the market capitalization of AVCO stock?
AVALON GLOBOCARE CORP (AVCO) has a market capitalization of 46.82M USD. This makes AVCO a Nano Cap stock.